Radiotherapy Can Decrease Locoregional Recurrence and Increase Survival in Mastectomy Patients With T1 to T2 Breast Cancer and One to Three Positive Nodes With Negative Estrogen Receptor and Positive Lymphovascular Invasion Status

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 2, 2010, Pages 516-522

  Yang, Po Sheng ^a,b   Chen, Chi Ming ^a   Liu, Mei Ching ^a   Jian, Jer Min ^a   Horng, Cheng Fang ^a   Liu, Ming Jiung ^a   Yu, Ben Long ^a   Lee, Ming Yuan ^a   Chi, Chin Wen ^b,c  

^a Sun Yat Sen Cancer Center   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Invasive breast cancer; Locoregional recurrence; Mastectomy; Radiotherapy; T1 2 N1

Indexed keywords

AXILLARY LYMPH NODES; BREAST CANCER; ESTROGEN RECEPTOR; HAZARD RATIO; LOCOREGIONAL RECURRENCE; LYMPHOVASCULAR INVASIONS; MULTI VARIATE ANALYSIS; OVERALL SURVIVAL; POSTMASTECTOMY RADIOTHERAPY; RADICAL MASTECTOMY; RISK FACTORS; STATISTICAL SIGNIFICANCE; TUMOR SIZE; UNIVARIATE ANALYSIS;

DECISION MAKING; MULTIVARIANT ANALYSIS; PESTICIDE EFFECTS;

RADIOTHERAPY;

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PACLITAXEL;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; VASCULAR TUMOR;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AXILLA; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MASTECTOMY, MODIFIED RADICAL; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; RECEPTORS, ESTROGEN; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR BURDEN;

EID: 77951869764     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.05.016     Document Type: Article

References (33)

1. Lee M.C., and Jagsi R. Postmastectomy radiation therapy: Indications and controversies. Surg Clin North Am 87 (2007) 511-526
2. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337 (1997) 949-955
3. Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353 (1999) 1641-1648
4. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337 (1997) 956-962
5. Harris J.R., Halpin-Murphy P., McNeese M., et al. Consensus statement on postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys 44 (1999) 989-990
6. Recht A., Edge S.B., Solin L.J., et al. Postmastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19 (2001) 1539-1569
7. Poortmans P. Evidence based radiation oncology: Breast cancer. Radiother Oncol 84 (2007) 84-101
8. Overgaard M., Nielsen H.M., and Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol 82 (2007) 247-253
9. Yildirim E., and Berberoglu U. Local recurrence in breast carcinoma patients with T(1-2) and 1-3 positive nodes: Indications for radiotherapy. Eur J Surg Oncol 33 (2007) 28-32
10. Olivotto I.A., Truong P.T., and Chua B. Postmastectomy radiation therapy: Who needs it?. J Clin Oncol 22 (2004) 4237-4239
11. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366 (2005) 2087-2106
12. Truong P.T., Berthelet E., Lee J., et al. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer 103 (2005) 2006-2014
13. Katz A., Buchholz T.A., Thames H., et al. Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: Implications for adjuvant irradiation. Int J Radiat Oncol Biol Phys 50 (2001) 397-403
14. Yu J.M., and Wang Y.S. Breast cancer radiotherapy: Controversies and perspectives. Chin Med J (Engl) 121 (2008) 1957-1959
15. Woodward W.A., Strom E.A., Tucker S.L., et al. Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation. Int J Radiat Oncol Biol Phys 57 (2003) 336-344
16. Poortmans P. A bright future for radiotherapy in breast cancer. Radiother Oncol 82 (2007) 243-246
17. Cheng J.C., Chen C.M., Liu M.C., et al. Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 52 (2002) 980-988
18. Kuske R.R. Adjuvant irradiation after mastectomy in women with one to three positive axillary nodes: Then no; now yes. Semin Radiat Oncol 9 (1999) 254-258
19. Fowble B., Gray R., Gilchrist K., et al. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J Clin Oncol 6 (1988) 1107-1117
20. Ragaz J., Olivotto I.A., Spinelli J.J., et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97 (2005) 116-126
21. Taghian A., Jeong J.H., Mamounas E., et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: Results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 22 (2004) 4247-4254
22. Clayton F. Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor. Cancer 68 (1991) 1309-1317
23. Neville A.M., Bettelheim R., Gelber R.D., et al. Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group. J Clin Oncol 10 (1992) 696-705
24. Fitzgibbons P.L., Page D.L., Weaver D., et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124 (2000) 966-978
25. Lee A.K., DeLellis R.A., Silverman M.L., et al. Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast. J Clin Oncol 8 (1990) 1457-1465
26. Katz A., Strom E.A., Buchholz T.A., et al. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys 50 (2001) 735-742
27. Recht A., Gray R., Davidson N.E., et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group. J Clin Oncol 17 (1999) 1689-1700
28. Nielsen H.M., Overgaard M., Grau C., et al. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: Long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol 24 (2006) 2268-2275
29. Katz A., Strom E.A., Buchholz T.A., et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: Implications for postoperative irradiation. J Clin Oncol 18 (2000) 2817-2827
30. Truong P.T., Jones S.O., Kader H.A., et al. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy. Int J Radiat Oncol Biol Phys 73 (2009) 357-364
31. Truong P.T., Olivotto I.A., Kader H.A., et al. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 61 (2005) 1337-1347
32. Whelan T.J., Julian J., Wright J., et al. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 18 (2000) 1220-1229
33. Patt D.A., Goodwin J.S., Kuo Y.F., et al. Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol 23 (2005) 7475-7482